Michel Meignan (M Meignan)

Publication Activity (10 Years)

Years Active: 2015-2022
Publications (10 Years): 6

Top Topics

Hodgkin Lymphoma

Top Venues

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

European journal of nuclear medicine and molecular imaging

This page only lists publications with an associated author ORCID identifier.

Publications

Luc-Matthieu Fornecker, Julien Lazarovici, Igor Aurer, René-Olivier Casasnovas, Anne-Claire Gac, Christophe Bonnet, Krimo Bouabdallah, Pierre Feugier, Lena Specht, Lysiane Molina, Mohamed Touati, Cécile Borel, Aspassia Stamatoullas, Emmanuelle Nicolas-Virelizier, Laurent Pascal, Pieternella J Lugtenburg, Nicola Di Renzo, Thierry Vander Borght, Alexandra Traverse-Glehen, Peggy Dartigues, Martin Hutchings, Annibale Versari, Michel Meignan, Massimo Federico, Marc André, null null
Brentuximab Vedotin Plus AVD for First-Line Treatment of Early-Stage Unfavorable Hodgkin Lymphoma (BREACH): A Multicenter, Open-Label, Randomized, Phase II Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2022)
René-Olivier Casasnovas, Reda Bouabdallah, Pauline Brice, Julien Lazarovici, Hervé Ghesquieres, Aspassia Stamatoullas, Jehan Dupuis, Anne-Claire Gac, Thomas Gastinne, Bertrand Joly, Krimo Bouabdallah, Emmanuelle Nicolas-Virelizier, Pierre Feugier, Judith Trotman, David Sibon, Christophe Bonnet, Alina Berriolo-Riedinger, Véronique Edeline, Marie Parrens, Diane Damotte, Diane Coso, Marc André, Michel Meignan, Cédric Rossi
Positron Emission Tomography-Driven Strategy in Advanced Hodgkin Lymphoma: Prolonged Follow-Up of the AHL2011 Phase III Lymphoma Study Association Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 40 (10) (2022)
Emmanuel Bachy, Vincent Camus, Catherine Thieblemont, David Sibon, René-Olivier Casasnovas, Loic Ysebaert, Gandhi Damaj, Stéphanie Guidez, Gian Matteo Pica, Won Seog Kim, Soon Thye Lim, Marc André, Alejandro Martin Martin Garcia-Sancho, María Jesus Peñarrubia, Philipp Bernhard Staber, Judith Trotman, Andreas Huettmann, Vittorio Stefoni, Alessandro Re, Philippe Gaulard, Marie-Hélène Delfau-Larue, Laurence de Leval, Michel Meignan, Ju Li, Judith Trotman, Richard Delarue
Romidepsin Plus CHOP Versus CHOP in Patients With Previously Untreated Peripheral T-Cell Lymphoma: Results of the Ro-CHOP Phase III Study (Conducted by LYSA). Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2021)
Stefan K Alig, Charles W Macaulay, David M Kurtz, Ulrich Dührsen, Andreas Huettmann, Christine Schmitz, Michael C Jin, Brian J Sworder, Andrea Garofalo, Mohammad Shahrokh Esfahani, Barzin Y Nabet, Joanne Soo, Florian Scherer, Alexander F M Craig, René-Olivier Casasnovas, Jason R Westin, Gianluca Gaidano, Davide Rossi, Mark J Roschewski, Wyndham H Wilson, Michel Meignan, Maximilian Diehn, Ash A Alizadeh
Short Diagnosis-to-Treatment Interval Is Associated With Higher Circulating Tumor DNA Levels in Diffuse Large B-Cell Lymphoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 39 (23) (2021)
Michel Meignan, Anne-Ségolène Cottereau
FDG-PET in PMBCL: which heterogeneity? Blood 132 (2) (2019)
A Gallamini, Michel Meignan
PET-guided clinical trials in Hodgkin lymphoma: to agree or not to agree, that is the reviewer's question. European journal of nuclear medicine and molecular imaging 45 (1) (2017)
Michel Meignan
Quantitative FDG-PET: a new biomarker in PMBCL. Blood 126 (8) (2015)